Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amsacrine evaluation.

T J Van Mouwerik, P M Caines, R Ballentine

    Drug Intelligence & Clinical Pharmacy
    |April 1, 1987
    PubMed
    Summary

    Amsacrine shows efficacy against leukemias and lymphomas. While it has side effects like bone marrow suppression, it remains valuable in acute leukemia combination therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of antibiotics, vitamin analogues and other compounds in experimental gas gangrene.

    The Journal of infectious diseases·2010
    Same author

    Nitrogen metabolism of Rana pipiens during embryonic development.

    The Journal of experimental zoology·2010
    Same author

    Drug usage evaluation: perspectives and reappraisal.

    Topics in hospital pharmacy management·1988
    Same author

    Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.

    Biochemical pharmacology·1987
    Same author

    Acquired immune deficiency syndrome and the management of associated opportunistic infections.

    Drug intelligence & clinical pharmacy·1983
    Same author

    Patient education on cancer chemotherapeutic agents.

    American pharmacy·1983

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Amsacrine is an antineoplastic agent investigated for various cancers.
    • It exhibits activity against adult and pediatric leukemias, Hodgkin's disease, and non-Hodgkin's lymphomas.

    Purpose of the Study:

    • To summarize the activity and toxicity profile of amsacrine.

    Main Methods:

    • Clinical trial data review.
    • Pharmacokinetic and pharmacodynamic analysis.

    Main Results:

    • Amsacrine demonstrates effectiveness in treating leukemias and lymphomas.
    • Hepatic metabolism is the primary elimination route; hepatic dysfunction impairs excretion.
    • Dose-related bone marrow suppression is the main side effect, alongside mucositis, nausea, vomiting, cardiotoxicity, liver dysfunction, and alopecia.

    Conclusions:

    • Amsacrine is an active agent in treating hematologic malignancies.
    • Its toxicity profile necessitates careful monitoring, especially in patients with liver dysfunction.
    • Amsacrine has a potential role in combination therapy for acute leukemias.

    Related Experiment Videos